Skip to content

Mind-body Approach and Gut Microbiota in Osteoarthritis

Mind-body Approach and Gut Microbiota in Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05186714
Enrollment
72
Registered
2022-01-11
Start date
2022-11-01
Completion date
2025-06-01
Last updated
2025-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

This exploratory study is to compares mechanisms of mind-body exercise with wellness education program on gut microbiota for osteoarthritis as a basis for a future large-scale trial.

Detailed description

This exploratory study is to determine the effect of mind-body exercise on gut microbiota in patients with osteoarthritis. We will randomize 80 eligible individuals who meet the American College of Rheumatology criteria for osteoarthritis into Tai Chi or wellness education interventions for 12 weeks. Using 16S rRNA amplicon sequencing of fecal DNA samples we will compare the changes in gut microbiota profiles using 16S rRNA gene amplicon sequencing, and quantity of Streptococcus species using quantitative PCR, as well as their association with clinical outcomes. This exploratory study will guide the development of theoretically informed, effective treatment for a high-risk population further enlighten us about the pathogenesis of metabolic osteoarthritis pain.This proposal will provide crucial preliminary knowledge of the mechanism underlying Tai Chi mind-body therapy for metabolic osteoarthritis.

Interventions

BEHAVIORALTai Chi versus wellness education

12 weeks of Tai Chi (2x/week) or a wellness education (2x/week)

Sponsors

Tufts Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 55 years * Fulfills the American College of Rheumatology Criteria for symptomatic OA * Baseline (Month 0) WOMAC pain subscale score ≥ 40

Exclusion criteria

* Dementia, neurological disease, cancer, cardiovascular disease, renal disease, liver disease, or other serious medical conditions limiting ability to participate in the programs. * Factors known or likely to impact the intestinal microbiota or known to be associated with microbial translocation: antibiotic or probiotic use within the previous 4 weeks, gastrointestinal morbidity (irritable bowel syndrome, inflammatory bowel disease, history of gastrointestinal cancer or surgical resection, or acute, severe gastrointestinal symptoms requiring medical attention), opportunistic infection, and evidence of hepatitis B or C virus infection

Design outcomes

Primary

MeasureTime frameDescription
Gut microbiotaFrom Week 0, to Week 12Changes in gut composition, relative abundance and diversity, and Streptococcus abundance

Secondary

MeasureTime frameDescription
Change in Hospital Anxiety and Depression ScaleFrom Week 0 to Week 12The Hospital Anxiety and Depression Scale (range 0-21, with higher scores indicating more severe symptoms).
Change in Body mass indexFrom Week 0 to Week 12Body mass index is measured as the weight (kg) divided by the height (m). squared
PROMIS-29From Week 0 to Week 12PROMIS-29 measure assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance).
Change in Western Ontario and McMaster University Index (WOMAC)From Week 0 to Week 12WOMAC version 3.1 questionnaire (pain subscale range, 0 \[no pain\]-20 \[extreme pain\]; the stiffness subscale range, 0 \[no stiffness\]-8 \[extreme stiffness\]; function subscale range, 0 \[no difficulty with daily activities\]-68 \[extreme difficulty\].
PROMIS Pain InterferenceFrom Week 0 to Week 12PROMIS Pain Interference score (short form 6b item short form evaluating the extent to which pain interferes with physical, emotional and social activities).
Arthritis Self-efficacyFrom Week 0 to Week 12Arthritis Self-efficacy Scale score (SD) (Range, 1-10)
Patient Global, 0-100 cm VASFrom Week 0 to Week 12Global knee pain assessment (range, 0 \[no pain\]-100 \[extreme pain\]),

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026